Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

DOXORUBICIN HYDROCHLORIDE

DOXORUBICIN HYDROCHLORIDE

Standard Dose
50MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview DOXORUBICIN HYDROCHLORIDE is listed in Drugs@FDA under application 208888 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient DOXORUBICIN HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 50MG/VIAL Sponsor AMNEAL Submission history Latest submission status date: 2023-07-12 00:00:00.

Structured Monograph

Clinical summary

Approval overview DOXORUBICIN HYDROCHLORIDE is listed in Drugs@FDA under application 208888 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient DOXORUBICIN HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 50MG/VIAL Sponsor AMNEAL Submission history Latest submission status date: 2023-07-12 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.